Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 3, 2013, Pages 385-391

  Chai, Da Min ^a,b   Bao, Zheng Qi ^a   Hu, Jian Guo ^a   Ma, Li ^a   Feng, Zhen Zhong ^a   Tao, Yi Sheng ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

E cadherin; esophageal squamous cell carcinoma; hypoxia inducible factor l ; prognosis; vasculogenic mimicry

Indexed keywords

CADHERIN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR MARKER;

ADULT; AGED; ARTICLE; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879315192     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1129-4     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA-Cancer J Clin, 2011,61(2):69-90
2. Tong L, Yuan S, Feng F, et al. Role of podoplanin expression in esophageal squamous cell carcinoma: a retrospective study. Dis Esophagus, 2012,25(1):72-80
3. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010,127(12):2893-2917
4. Zhao N, Sun BC, Sun T, et al. Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2. Med Oncol, 2012,29(5):3599-3607
5. Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol, 1999,155(3):739-752
6. Shannon AM, Bouchier-Hayes DJ, Condron CM, et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev, 2003,29(4): 297-307
7. Park SY, Billiar TR, Seol DW. Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Biochem Bioph Res Commun, 2002,291(1):150-153
8. Sun B, Zhang D, Zhang S, et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer lett, 2007,249(2):188-197
9. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer, 2002,2(1):38-47
10. Morales CP, Souza RF, Spechler SJ. Hallmarks of cancer progression in Barrett's oesophagus. Lancet, 2002,360(9345):1587-1589
11. Lin DC, Du XL, Wang MR. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus, 2009,22(1):9-20.
12. Xu XL, Ling ZQ, Chen SZ, et al. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Dis Esophagus, 2013 (ahead of print)
13. Lai CY, Schwartz BE, Hsu MY. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res, 2012,72(19):5111-5118
14. Liu T, Sun B, Zhao X, et al. HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma. J Cell Mol Med, 2012,17(1):116-22
15. Ahmadi SA, Moinfar M, Gohari Moghaddam K, et al. Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch Iran Med, 2010,13(6):498-503
16. El Hallani S, Boisselier B, Peglion F, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain, 2010,133(Pt 4):973-982
17. Liu WB, Xu GL, Jia WD, et al. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Med Onco, 2011,28(Suppl 1):S228-238
18. Wu S, Yu L, Wang D, et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC cancer, 2012,12:535
19. Folberg R, Maniotis AJ. Vasculogenic mimicry. APMIS, 2004,112(7-8):508- 525
20. Zhang S, Guo H, Zhang D, et al. Microcirculation patterns in different stages of melanoma growth. Oncol Rep, 2006,15(1):15-20
21. Zhang S, Zhang D, Sun B. Vasculogenic mimicry: current status and future prospects. Cancer lett, 2007,254(2): 157-164
22. Sun W, Shen ZY, Zhang H, et al. Overexpression of HIF-1alpha in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis. Oncol Rep, 2012,27(6):1990-2002
23. Zhao H, Gu XM. Study on vasculogenic mimicry in malignant esophageal stromal tumors. World J Gastroentero, 2008,14(15):2430-2433
24. Ding ZL, Wang L, Zhu H, et al. Effect of Akt on the function of esophageal squamous cancer cell Eca109 and the expression of vasculogenic mimicry-related genes. Zhonghua Yixue Zazhi (Chinese), 2012,92(36):2556-2560
25. Cai XS, Jia YW, Mei J, et al. Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chinese Med J, 2004,117(1):94-98
26. Xu O, Li XM, Wang MX, et al. Expression of hypoxia inducible factor-1alpha and correlated target genes in human laryngeal carcinoma. Zhonghua Erbiyanhou Toujing Waike Zazhi (Chinese), 2012,47(4):330-333
27. Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer, 2012,12(1):9-22
28. Chai CY, Chen WT, Hung WC, et al. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma. J Clin Pathol, 2008,61(5):658-664
29. Wu XH, Qian C, Yuan K. Correlations of hypoxia-in-ducible factor-1alpha/hypoxia-inducible factor-2alpha expression with angiogenesis factors expression and prognosis in non-small cell lung cancer. Chinese Med J Peking, 2011,124(1):11-18
30. Chung Y, Law S, Kwong DL, et al. Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus, 2011,24(1): 49-55
31. Chung Y, Lam AK, Luk JM, et al. Altered E-cadherin expression and p120 catenin localization in esophageal squamous cell carcinoma. Ann Surg Oncol, 2007,14(11): 3260-3267
32. Chan AO, Wong BC, Lan HY, et al. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J Gastroen Hepatol, 2003,18(5): 534-539
33. Jawhari AU, Noda M, Farthing MJ, et al. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Brit J Cancer, 1999, 80(3-4):322-330
34. Sarrio D, Perez-Mies B, Hardisson D, et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene, 2004,23(19):3272-3283
35. Prognostic significance of CyclinD1 and E-cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysis. J Am Coll Surg, 2001, 192(6):708-718
36. Zhao XJ, Li H, Chen H, et al. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroentero, 2003,9(2):225-232
37. Solanas G, Porta-de-la-Riva M, Agusti C, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci, 2008,121(Pt 13):2224-2234
38. Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PloS one, 2009,4(2):e4580
39. Takahashi Y, Nishikawa M, Suehara T, et al. Gene silencing of beta-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int J Cancer, 2008,123(10):2315-2320